Navigation Links
Texas-based consortium announces groundbreaking vaccine research program
Date:2/24/2010

COLLEGE STATION, Texas - Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.

Project GreenVax, which utilizes tobacco plants rather than the current egg-based vaccine technology, holds the promise of shortening vaccine production to a fraction of the current time, allowing rapid response to newly emerging viruses not possible with current technology. The majority of funding for the project is provided by the Defense Advanced Research Projects Agency (DARPA).

The Consortium, comprised of G-Con, LLC and The Texas A&M University System, designed Project GreenVax for a projected final scale capacity of 100 million doses per month. The flexibility of the plant-based system, combined with its low cost and ability to massively scale, may provide vaccine protection not only to citizens of the United States, but to many parts of the world that cannot currently afford vaccines.

The GreenVax Project will be headquartered on a secure, 21-acre site on the campus of the Texas A&M Health Science Center in Bryan, Texas. The custom-designed 145,000 square foot biotherapeutic production facility will be constructed and managed by G-Con. The company will integrate their proprietary modular, mobile, clean room "pods" in which the specialized purification and laboratory equipment will be located. These pods, as well as the flexible processes and facility design that led to the GreenVax project, were designed and developed for the National Center for Therapeutics Manufacturing (NCTM) - a State of Texas core biological pharmaceutical manufacturing, research and education facility now in construction on the Texas A&M University campus, under the management of the Texas Engineering Experiment Station (TEES) and supported by the Texas Emerging Technology Fund.

"Project GreenVax and the NCTM are game-changers. They have the potential to transform not just vaccine production, but the entire biopharmaceutical manufacturing industry," said Dr. Brett Giroir, vice chancellor for research for the A&M System and executive director of the Institute for Innovative Therapeutics (IIT), the newly established institute representing the partnership between the system's multiple state-of-the-art research facilities.

"Although the initial goal is to produce influenza vaccines," added Dr. Barry Holtz, president of G-Con, "plant-based production is highly adaptable to other infectious diseases and even cancer."


'/>"/>

Contact: Jason Cook
jason.cook@tamu.edu
979-845-2217
Texas A&M University
Source:Eurekalert

Related medicine news :

1. Texas-Based Regency Nursing and Rehabilitation Centers to Pay U.S. $4 Million to Resolve False Claims Act Allegations
2. Texas-Based Mobile Health Screening Company Expands into Dallas-Fort Worth
3. Regional Radiology Groups Form a National Consortium
4. MIT's Center for Transportation & Logistics Announces new Environmental Performance Consortium at Annual Crossroads Conference
5. The Security Consortium Announces Support for White House Cyber Chief Schmidt
6. University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources
7. University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services
8. Turkey Genome Sequencing Consortium awarded $0.9 million from USDA
9. UT Southwestern receives continued NIH funding for Inner City Asthma Consortium
10. Pitt researcher to co-direct national consortium on facial birth defects
11. Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... Amir Qureshi, MD is ... powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita SCS System has been ... pleased to be the first in Arkansas to introduce the most powerful SCS system ...
(Date:5/26/2017)... ... ... A new analysis of community health data reveals that four out of ... With the average cost of healthcare rising and the U.S. senior population expected to ... affordability of where they live. An annual 2017 report looked at a variety of ...
(Date:5/26/2017)... ... 2017 , ... via seating is proud to partner with ... specifically designed for clinical areas. Genie Copper Mesh is a crossover chair for ... provide customers with a game changing chair that is affordably priced,” Chas Hepler ...
(Date:5/26/2017)... ... May 26, 2017 , ... After raising nearly $30,000 on ... will continue to be available at a discounted crowdfunding price on Indiegogo . ... they are, I also wanted to bring a fidget toy to the market that ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Silver Birch ... community, which is located on more than four acres of land at 5620 Sohl ... , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each of ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
(Date:5/8/2017)... , May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: ... Inc. ("WRB"), a health care service center company ... WRB specializes in relationship management programs for leading ... WRB will join Envoy ... support services for manufacturers, biotech firms, and other service ...
Breaking Medicine Technology: